Our laboratory develops and applies advanced proteomics methods to study human health. We use mass spectrometric technology to answer fundamental questions in cell biology and to study human diseases including cancer, Alzheimer’s, diabetes, mental disorders, cancer, heart failure, obesity, asthma, among several others. The Proteomics Platform provides best-in-class mass spectrometry-based proteomic technologies and analysis capabilities to the Broad community and collaborators throughout the Korea and beyond, with the goal of addressing important questions in biology, chemistry, and clinical sciences through intensive collaboration. We continue to adopt and pioneer development of cutting-edge sample processing, data collection, and data analysis technologies of greatest importance.